Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:DGX NYSE:DVA NASDAQ:IDXG NYSE:LH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDGXQuest Diagnostics$170.81+2.0%$174.01$144.87▼$182.38$18.72B0.461.36 million shs1.42 million shsDVADaVita$138.44-1.4%$140.44$131.76▼$179.60$10.60B1.09672,836 shs686,266 shsIDXGInterpace Biosciences$0.83-3.5%$8.06$2.57▼$10.42$3.66M0.766,816 shs8,721 shsLHLabcorp$261.34+0.5%$256.06$209.38▼$283.47$21.77B0.78851,657 shs652,995 shs7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDGXQuest Diagnostics+2.10%+1.44%-3.26%-4.02%+20.09%DVADaVita-1.31%-4.55%-2.98%-1.75%+1.33%IDXGInterpace Biosciences-3.96%-9.47%+13.91%+28.36%-23.21%LHLabcorp+0.69%-1.18%+0.50%+5.43%+21.31%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationDGXQuest Diagnostics4.9458 of 5 stars2.35.04.24.73.52.52.5DVADaVita4.445 of 5 stars2.02.00.04.52.92.53.8IDXGInterpace BiosciencesN/AN/AN/AN/AN/AN/AN/AN/ALHLabcorp4.5543 of 5 stars2.34.02.54.23.82.51.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDGXQuest Diagnostics 2.67Moderate Buy$186.008.89% UpsideDVADaVita 2.00Hold$167.4020.92% UpsideIDXGInterpace Biosciences 0.00N/AN/AN/ALHLabcorp 2.62Moderate Buy$289.5810.81% UpsideCurrent Analyst Ratings BreakdownLatest IDXG, LH, DGX, and DVA Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/25/2025LHLabcorpUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$282.00 ➝ $305.007/25/2025LHLabcorpTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$290.00 ➝ $310.007/25/2025LHLabcorpEvercore ISISubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$285.00 ➝ $300.007/25/2025LHLabcorpMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$283.00 ➝ $306.007/25/2025LHLabcorpRobert W. BairdSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$290.00 ➝ $302.007/23/2025DGXQuest DiagnosticsEvercore ISISubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price Target$185.007/23/2025DGXQuest DiagnosticsWilliam BlairSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform7/23/2025DGXQuest DiagnosticsTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetHold ➝ Hold$190.00 ➝ $192.007/23/2025DGXQuest DiagnosticsDeutsche Bank AktiengesellschaftSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetHold ➝ Hold$160.00 ➝ $178.007/18/2025DGXQuest DiagnosticsUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$176.00 ➝ $175.007/18/2025LHLabcorpUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$284.00 ➝ $282.00(Data available from 8/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDGXQuest Diagnostics$9.87B1.93$13.78 per share12.40$64.97 per share2.63DVADaVita$12.82B0.82$18.86 per share7.34$4.83 per share28.66IDXGInterpace Biosciences$40.21M0.09$0.42 per share1.99($14.16) per share-0.06LHLabcorp$13.01B1.68$22.51 per share11.61$101.23 per share2.58Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDGXQuest Diagnostics$871M$8.3520.4616.282.229.01%15.24%6.64%N/ADVADaVita$936.34M$10.0913.7210.890.976.63%176.11%4.66%8/5/2025 (Estimated)IDXGInterpace Biosciences$800KN/A0.00∞N/A10.39%-8.09%37.14%N/ALHLabcorp$746M$9.0628.8514.901.665.66%15.45%7.02%N/ALatest IDXG, LH, DGX, and DVA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/5/2025Q2 2025DVADaVita$2.70N/AN/AN/A$3.36 billionN/A7/24/2025Q2 2025LHLabcorp$4.14$4.35+$0.21$2.84$3.49 billion$3.53 billion7/22/2025Q2 2025DGXQuest Diagnostics$2.57$2.62+$0.05$2.47$2.73 billion$2.76 billion5/12/2025Q1 2025DVADaVita$1.75$2.00+$0.25$2.00$3.22 billion$3.22 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthDGXQuest Diagnostics$3.201.87%N/A38.32%14 YearsDVADaVitaN/AN/AN/AN/AN/AIDXGInterpace BiosciencesN/AN/AN/AN/AN/ALHLabcorp$2.881.10%N/A31.79%N/ALatest IDXG, LH, DGX, and DVA DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date7/10/2025LHLabcorpquarterly$0.721.11%8/28/20259/11/20255/14/2025DGXQuest Diagnosticsquarterly$0.801.86%7/7/20257/7/20257/21/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDGXQuest Diagnostics0.711.090.99DVADaVita23.181.251.20IDXGInterpace BiosciencesN/A0.590.59LHLabcorp0.611.501.32Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDGXQuest Diagnostics88.06%DVADaVita90.12%IDXGInterpace Biosciences5.73%LHLabcorp95.94%Insider OwnershipCompanyInsider OwnershipDGXQuest Diagnostics8.16%DVADaVita2.00%IDXGInterpace Biosciences5.50%LHLabcorp0.84%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDGXQuest Diagnostics56,000111.82 million102.70 millionOptionableDVADaVita76,00075.50 million73.99 millionOptionableIDXGInterpace Biosciences1524.41 million4.17 millionNot OptionableLHLabcorp70,00083.70 million83.00 millionOptionableIDXG, LH, DGX, and DVA HeadlinesRecent News About These CompaniesDwight Gary Gilliland Sells 2,000 Shares of Labcorp Holdings Inc. (NYSE:LH) Stock1 hour ago | insidertrades.comMackenzie Financial Corp Grows Stake in Labcorp Holdings Inc. (NYSE:LH)3 hours ago | marketbeat.comZurcher Kantonalbank Zurich Cantonalbank Purchases 1,222 Shares of Labcorp Holdings Inc. (NYSE:LH)3 hours ago | marketbeat.comTD Asset Management Inc Purchases 10,411 Shares of Labcorp Holdings Inc. (NYSE:LH)3 hours ago | marketbeat.comLabcorp Holdings Inc. (NYSE:LH) Shares Purchased by Natixis Advisors LLCAugust 1 at 6:04 AM | marketbeat.comTredje AP fonden Increases Holdings in Labcorp Holdings Inc. (NYSE:LH)August 1 at 5:54 AM | marketbeat.com1 Healthcare Stock to Consider Right Now and 2 That UnderwhelmJuly 31 at 5:14 PM | uk.finance.yahoo.comThe 5 Most Interesting Analyst Questions From Labcorp’s Q2 Earnings CallJuly 31 at 5:14 PM | msn.comLabcorp Holdings (LH) Unveils Test Finder: AI Tool for Streamlined Lab Test SelectionJuly 31 at 5:14 PM | finance.yahoo.comWhy Labcorp Holdings (LH) is a Top Momentum Stock for the Long-TermJuly 31 at 10:51 AM | zacks.comPacer Advisors Inc. Decreases Position in Labcorp Holdings Inc. (NYSE:LH)July 31 at 4:49 AM | marketbeat.comLabcorp Holdings (LH) Launches CE-Marked Test for Cancer Care Expansion in EUJuly 30 at 12:47 AM | finance.yahoo.comLabcorp Introduces Test Finder, a First-of-Its-Kind Generative AI Tool to Simplify Lab Test SearchJuly 30 at 7:12 AM | prnewswire.comInsider Selling: Labcorp Holdings Inc. (NYSE:LH) Director Sells 3,500 Shares of StockJuly 29, 2025 | marketbeat.comWhy Labcorp Holdings (LH) is a Top Value Stock for the Long-TermJuly 29, 2025 | zacks.comFirst Foundation Advisors Has $5.31 Million Stake in Labcorp Holdings Inc. (NYSE:LH)July 29, 2025 | marketbeat.comLabcorp Achieves IVDR CE-Marking for PGDx elio™ tissue complete in the EUJuly 29, 2025 | prnewswire.comLabcorp Holdings Inc. (NYSE:LH) Director Kerrii B. Anderson Sells 3,500 SharesJuly 29, 2025 | insidertrades.comFY2026 EPS Estimates for Labcorp Increased by AnalystJuly 29, 2025 | americanbankingnews.comGalvin Gaustad & Stein LLC Cuts Position in Labcorp Holdings Inc. (NYSE:LH)July 28, 2025 | marketbeat.comSkandinaviska Enskilda Banken AB publ Boosts Stock Position in Labcorp Holdings Inc. (NYSE:LH)July 28, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All Headlines3 Defense Leaders Set to Gain From Rising Military SpendBy Chris Markoch | July 5, 2025View 3 Defense Leaders Set to Gain From Rising Military Spend3 Short Squeeze Candidates With Big Catalysts on the HorizonBy Dan Schmidt | July 25, 2025View 3 Short Squeeze Candidates With Big Catalysts on the HorizonHow a Government Loan Changes the Game for Plug PowerBy Jeffrey Neal Johnson | July 4, 2025View How a Government Loan Changes the Game for Plug PowerAmerica Wants Drone Dominance: Are These Stocks Ready to Soar?By Chris Markoch | July 20, 2025View America Wants Drone Dominance: Are These Stocks Ready to Soar?Super Micro Computer Sees Unusual Volume—Catalyst Ahead?By Gabriel Osorio-Mazilli | July 25, 2025View Super Micro Computer Sees Unusual Volume—Catalyst Ahead?IDXG, LH, DGX, and DVA Company DescriptionsQuest Diagnostics NYSE:DGX$170.81 +3.40 (+2.03%) Closing price 08/1/2025 03:59 PM EasternExtended Trading$170.86 +0.04 (+0.03%) As of 08/1/2025 04:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.DaVita NYSE:DVA$138.44 -1.93 (-1.37%) Closing price 08/1/2025 03:59 PM EasternExtended Trading$138.43 -0.01 (-0.01%) As of 08/1/2025 06:23 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.Interpace Biosciences NASDAQ:IDXGInterpace Biosciences, Inc. provides molecular diagnostic tests, bioinformatics, and pathology services for evaluating cancer risk in the United States. The company offers PancraGEN, a pancreatic cyst and pancreaticobiliary solid lesion genomic test that helps physicians better assess risk of pancreaticobiliary cancers using its PathFinderTG platform; and ThyGeNEXT, an oncogenic mutation panel to identify malignant thyroid nodules. It also provides ThyraMIR assesses thyroid nodules for risk of malignancy utilizing a proprietary microRNA gene-expression assay; and RespriDx, a genomic test that helps physicians to differentiate metastatic or recurrent lung cancer. The company also provides pharmacogenomics testing, genotyping, biorepository, and other customized services to the pharmaceutical and biotech industries. It primarily serves physicians, hospitals, and clinics. The company was formerly known as Interpace Diagnostics Group, Inc. and changed its name to Interpace Biosciences, Inc. in November 2019. Interpace Biosciences, Inc. was incorporated in 1986 and is headquartered in Parsippany, New Jersey.Labcorp NYSE:LH$261.34 +1.26 (+0.48%) Closing price 08/1/2025 03:59 PM EasternExtended Trading$261.42 +0.09 (+0.03%) As of 08/1/2025 04:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Labcorp Holdings, Inc. engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Alphabet Gains Momentum as Sentiment on Wall Street Improves Amazon's Earnings: What Comes Next and How to Play It Apple Stock: Big Earnings, Small Move—Time to Buy? Tesla Teams With Samsung—Will Other Chipmakers Follow? Will Hims & Hers Fall Along With Novo Nordisk? UPS's 7.5% Dividend: A Blue-Chip Stock on a Once-in-a-Decade Sale AbbVie Stock Eyes Breakout as Pipeline and Profits Grow Why Bloom Energy Stock Could Break to New Highs Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
